Insider Trades22 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Buy | NUVB | Philippe Sauvage | Chief Financial Officer | 40,000 | $2.17 | $2.0B | -40.51% | +166.06% | $86.8K | +3.25% | — | Buy Now |
| Jun 23, 2026 | Sell | NUVB | Philippe Sauvage | Chief Financial Officer | 95,336 | $4.09 | $2.0B | -40.51% | +166.06% | $389.8K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | NUVB | Kerry Wentworth | CHIEF REGULATORY OFFICER | 126,000 | $4.47 | $2.0B | -40.51% | +166.06% | $563.8K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | NUVB | Stacy Markel | CHIEF PEOPLE OFFICER | 250,000 | $3.93 | $2.0B | -40.51% | +166.06% | $982.4K | +0.00% | 10b5-1 | Buy Now |
| Apr 17, 2026 | Sell | NUVB | Kerry Wentworth | CHIEF REGULATORY OFFICER | 73,500 | $3.97 | $2.0B | -40.51% | +166.06% | $292.0K | +0.00% | 10b5-1 | Buy Now |
| Apr 17, 2026 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 100,000 | $3.48 | $2.0B | -40.51% | +166.06% | $348.0K | +0.00% | 10b5-1 | Buy Now |
| Apr 6, 2026 | Sell | NUVB | Kerry Wentworth | CHIEF REGULATORY OFFICER | 400,000 | $3.21 | $2.0B | -40.51% | +166.06% | $1.3M | +0.00% | 10b5-1 | Buy Now |
| Dec 1, 2025 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 300,000 | $5.38 | $2.0B | -40.51% | +166.06% | $1.6M | +0.00% | — | Buy Now |
| Nov 25, 2025 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 40,000 | $5.68 | $2.0B | -40.51% | +166.06% | $227.2K | +0.00% | — | Buy Now |
| Nov 20, 2025 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 40,000 | $4.44 | $2.0B | -40.51% | +166.06% | $177.5K | +0.00% | — | Buy Now |
| Nov 20, 2025 | Sell | NUVB | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 738,102 | $4.56 | $2.0B | -40.51% | +166.06% | $3.4M | +0.00% | — | Buy Now |
| Nov 19, 2025 | Sell | NUVB | David C. Hanley | CHIEF TECHNICAL OPERATIONS | 400,000 | $4.50 | $2.0B | -40.51% | +166.06% | $1.8M | +0.00% | — | Buy Now |
| Nov 17, 2025 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 60,000 | $3.40 | $2.0B | -40.51% | +166.06% | $204.1K | +0.00% | — | Buy Now |
| Oct 27, 2025 | Sell | NUVB | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 200,000 | $3.38 | $2.0B | -40.51% | +166.06% | $676.5K | +0.00% | 10b5-1 | Buy Now |
| Jun 18, 2025 | Buy | NUVB | Stacy Markel | CHIEF PEOPLE OFFICER | 10,000 | $1.71 | $2.0B | -40.51% | +166.06% | $17.1K | +51.04% | — | Buy Now |
| Jun 16, 2025 | Buy | NUVB | Philippe Sauvage | Chief Financial Officer | 7,300 | $1.81 | $2.0B | -40.51% | +166.06% | $13.2K | +85.84% | — | Buy Now |
| Jun 16, 2025 | Buy | NUVB | Kerry Wentworth | CHIEF REGULATORY OFFICER | 50,000 | $1.79 | $2.0B | -40.51% | +166.06% | $89.7K | +192.31% | — | Buy Now |
| Jun 16, 2025 | Buy | NUVB | Colleen Sjogren | Chief Commercial Officer | 50,000 | $1.81 | $2.0B | -40.51% | +166.06% | $90.3K | +161.29% | — | Buy Now |
| Jun 16, 2025 | Buy | NUVB | David Hung | PRESIDENT AND CEO | 500,000 | $1.79 | $2.0B | -40.51% | +166.06% | $893.5K | +0.85% | — | Buy Now |
| May 2, 2025 | Sell | NUVB | Dongfang Liu | CHIEF MEDICAL OFFICER | 40,000 | $2.22 | $2.0B | -40.51% | +166.06% | $88.8K | +0.00% | 10b5-1 | Buy Now |
| Apr 4, 2025 | Buy | NUVB | David Hung | PRESIDENT AND CEO | 500,000 | $1.64 | $2.0B | -40.51% | +166.06% | $820.2K | +0.43% | — | Buy Now |
| Nov 11, 2024 | Sell | NUVB | Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | 56,361 | $2.89 | $2.0B | -40.51% | +166.06% | $162.9K | -1.44% | — | Buy Now |